Afrezza, Insulin Inhaler Therapy For Diabetes, Succeeds In Studies
Afrezza is the flagship product of MannKind, whose shares have risen nearly 50 percent over the past three months in anticipation
afrezza insulin inhaler therapy diabetes succeed studies afrezza flagship product mannkind share rise nearly percent past month anticipation